Dermatophyte (tinea) infections
Goldstein A, Goldstein B
Topical corticosteroids are not recommended as first line treatment option for dermatophytes. Despite the possibility of accelerating healing time, the combined use of antifungal and corticosteroid products has an increased risk for topical corticosteroid-induced skin atrophy. Therefore, combining the products in treatment introduces patients to an unnecessary risk and side effect that can be avoided by using antifungal products singularly.